TNF and chronic kidney disease: AST-120 serum treatment significantly reduced NO and TNF-α release from astrocytes (Figure 2A–F, respectively), thus highlighting that IS contributes, among the various uremic toxins present in serum of CKD patients, to NO and TNF-α release from astrocytes during inflammation.